Results 151 to 160 of about 12,367 (201)

Circulating exhausted CD8+ effector memory cells differentiate immune checkpoint inhibitor-induced liver injury from other acute immune-mediated liver injuries. [PDF]

J Immunother Cancer
Astbury S, Atallah E, Grove JI, Bozward AG, Davies SP, Sheehan MJ, Kumpf SW, Qian J, Krajewska NM, Wootton GE, Lingaya MR, Kresnik D, Radulescu F, Rao A, Franks H, Ruiz-Ortega L, Riveiro-Barciela M, Ramaiah SK, Lanz TA, Ji C, Patel PM, Oo YH, Aithal GP.   +22 more
europepmc   +1 more source

AI-enhanced clinical trial-in-a-dish platform for improved DILI risk classification and mechanistic insights into hepatotoxicity. [PDF]

Front Toxicol
Cherradi S, Roux S, Bailleux C, Devic C, Debaigt C, Guerda K, Luciano S, Dalle M, Duong HT.   +8 more
europepmc   +1 more source

Decoding liver injury in cystic fibrosis: How to tell drug-induced liver injury from cystic fibrosis liver disease. [PDF]

World J Gastroenterol
Lee J, Yekula A, Wexler A, Zhuang W, Elangovan A, Rosario J, Burger P, Ramaraju G, Addissie B, Lim N, Narkewicz MR, Twohig P.   +11 more
europepmc   +1 more source

Machine learning-assisted analysis of serum metabolomics for identifying biomarkers in intrinsic and idiosyncratic drug-induced liver injury. [PDF]

Front Pharmacol
Wei X, Wei J, Huang Y, Lian S.
europepmc   +1 more source

Atorvastatin-Associated Liver Injury: Outcome After Statin Rechallenge. [PDF]

Fundam Clin Pharmacol
Bertin B, Lacotte V, Cracowski JL, Gaiffe A, Dumortier J, Vial T.   +5 more
europepmc   +1 more source

Insights into the Biochemical and Immune Mechanisms in Drug-Induced Liver Injury Pathogenesis. [PDF]

Chem Res Toxicol
Saville E, Wells G, Farrell L, Naisbitt DJ, Meng X.   +4 more
europepmc   +1 more source

Ⅰ型自己免疫性肝炎における新しい血清学的マーカーとしての抗PD-1抗体 [PDF]

, 2015
Matsumori, Kazuyuki
core  

Drug-Induced Cholestasis Secondary to Meropenem in an Elderly Patient: Report of A Rare Case. [PDF]

Cureus
Shrestha A, Suliman A, Bazrbachi T, Kim SE.   +3 more
europepmc   +1 more source

Potential Therapeutic Strategies for Steatosis, Oxidative Stress, Inflammation, and Fibrosis in Liver Disease. [PDF]

Int J Mol Sci
Muriel P, Vargas-Pozada EE, Márquez-Quiroga LV, Ramos-Tovar E.   +3 more
europepmc   +1 more source